Vector and Helper Genome Rearrangements Occur During Production of Helper-Dependent Adenoviral Vectors

被引:6
|
作者
Ahn, Miwon [1 ]
Gamble, Aisha [1 ]
Witting, Scott R. [1 ]
Magrisso, Jack [3 ]
Surendran, Sneha [1 ]
Obici, Silvana [3 ]
Morral, Nuria [1 ,2 ]
机构
[1] Indiana Univ Sch Med, Dept Med & Mol Genet, Indianapolis, IN 46202 USA
[2] Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA
[3] Univ Cincinnati, Metab Dis Inst, Obes Res Ctr, Cincinnati, OH 45237 USA
基金
美国国家卫生研究院;
关键词
HAIRPIN RNA EXPRESSION; GENE-TRANSFER; IN-VIVO; REGULATED EXPRESSION; PACKAGING SIGNAL; SYSTEM; LIVER; DELIVERY; CRE; DNA;
D O I
10.1089/hgtb.2012.198
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Helper-dependent adenoviral vectors (HD Ad) hold extreme promise for gene therapy of human diseases. All viral genes are deleted in HD Ad vectors, and therefore, the presence of a helper virus is required for their production. Current methods to minimize helper contamination in large-scale preparations rely on the use of the Cre/loxP system. The inclusion of loxP sites flanking the packaging signal results in its excision in the presence of Cre recombinase, preventing helper genome encapsidation. It is well established that the level of Cre recombinase activity is important in determining the degree of helper contamination. However, there is little information on other mechanisms that could also play an important role. We have generated several HD Ad vectors containing a rapalog-inducible system to regulate transgene expression, or LacZ under the control of the elongation factor 1 alpha promoter. Large-scale production of these vectors resulted in abundant helper contamination. Viral DNA analysis revealed the presence of rearrangements between vector and helper genomes. The rearrangements involved a helper DNA molecule with a fragment of the left arm of the HD Ad vector, including its ITR, packaging signal, and some stuffer sequence. Overall, our data suggest that helper DNA molecules that accumulate after Cre recombinase activity are prone to rearrangements, resulting in helper genomes that have incorporated a packaging signal from the vector. Helper particles with rearranged genomes have a growth advantage. This study identifies a novel mechanism leading to helper contamination during helper-dependent adenoviral vector production.
引用
收藏
页码:1 / 10
页数:10
相关论文
共 50 条
  • [1] Helper-dependent adenoviral vectors
    Zhou, H
    Pastore, L
    Beaudet, AL
    [J]. GENE THERAPY METHODS, 2002, 346 : 177 - 198
  • [2] Enhancement of Helper-Dependent Adenoviral Vector Production
    Bandara, Ranmal Avinash
    Duan, Rongqi
    Li, Jun
    Hu, Jim
    [J]. MOLECULAR THERAPY, 2020, 28 (04) : 202 - 202
  • [3] Improved system for helper-dependent adenoviral vector production
    Palmer, D
    Ng, P
    [J]. MOLECULAR THERAPY, 2003, 8 (05) : 846 - 852
  • [4] Replication and packaging of helper-dependent adenoviral vectors
    Sato, M
    Suzuki, S
    Kubo, S
    Mitani, K
    [J]. GENE THERAPY, 2002, 9 (07) : 472 - 476
  • [5] Replication and packaging of helper-dependent adenoviral vectors
    M Sato
    S Suzuki
    S Kubo
    K Mitani
    [J]. Gene Therapy, 2002, 9 : 472 - 476
  • [6] Helper-dependent adenoviral vectors for gene therapy
    Palmer, DJ
    Ng, P
    [J]. HUMAN GENE THERAPY, 2005, 16 (01) : 1 - 16
  • [7] Advances in helper-dependent adenoviral vector research
    Segura, Maria M.
    Alba, Raul
    Bosch, Assumpcio
    Chillon, Miguel
    [J]. CURRENT GENE THERAPY, 2008, 8 (04) : 222 - 235
  • [8] Expanded-capacity adenoviral vectors - the helper-dependent vectors
    Morsy, MA
    Caskey, CT
    [J]. MOLECULAR MEDICINE TODAY, 1999, 5 (01): : 18 - 24
  • [9] Helper-dependent adenoviral vectors in experimental gene therapy
    Józkowicz, A
    Dulak, J
    [J]. ACTA BIOCHIMICA POLONICA, 2005, 52 (03) : 589 - 599
  • [10] Generation of helper-dependent adenoviral vectors by homologous recombination
    Toietta, G
    Pastore, L
    Cerullo, V
    Finegold, M
    Beaudet, AL
    Lee, B
    [J]. MOLECULAR THERAPY, 2002, 5 (02) : 204 - 210